<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04458727</url>
  </required_header>
  <id_info>
    <org_study_id>EPICURE</org_study_id>
    <nct_id>NCT04458727</nct_id>
  </id_info>
  <brief_title>Evaluation of Multi-modal Supportive Actions in Outpatient Cardiac Rehabilitation in Subjects With Cardiovascular Disease</brief_title>
  <acronym>EPICURE</acronym>
  <official_title>Auswertung Von Multi-modalen unterstützenden Maßnahmen in Der Ambulant Kardiologischen Rehabilitation Bei Patienten Mit Einer kardiovaskulären Erkrankung</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>AIT Austrian Institute of Technology GmbH</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Cardiomed Kardiologisches Rehabilitationszentrum GmbH Linz</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>PKA Private Krankenanstalt Wels Betriebs Gesellschaft mit b. H.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Gemeinnützige Salzburger Landeskliniken Betriebsgesellschaften</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Medreha GmbH</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>ZARG - Zentrum für ambulante Rehabilitation Graz GmbH</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>REHAmed-tirol GmbH Innsbruck</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Universität Innsbruck</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>AIT Austrian Institute of Technology GmbH</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cariovascular diseases (CVD) are the most common cause of death worldwide with high micro- as&#xD;
      well as macro-economic burden. Several modifiable risk factors increase the probability of&#xD;
      contracting a CVE. These risk factors can be positively influenced by a cardiac&#xD;
      rehabilitation measure (CR), which has been shown to reduce mortality in CVD patients and to&#xD;
      reduce the economic burden. An increase in physical activity and performance are central&#xD;
      goals in CR, as they have a positive effect on several cardiovascular risk factors and&#xD;
      correlate strongly with a reduction in mortality in CVD patients. These goals can be achieved&#xD;
      in most CVD patients but can only be achieved by a modification of lifestyle.&#xD;
&#xD;
      In order to positively influence this lifestyle modification beyond the duration of the CR&#xD;
      measure and thus in the long term, CR Phase II should begin as soon as the patient fulfils&#xD;
      one of the well-defined inclusion criteria. CR Phase II can be carried out as an inpatient or&#xD;
      outpatient procedure and depends on the patient's state of health, personal preference and&#xD;
      availability of an outpatient CR facility in the vicinity of the patient. In the Austrian&#xD;
      healthcare system, inpatient CR and thus differs from other European countries. After&#xD;
      completion of phase II, the patient is offered an outpatient phase III with weekly visits to&#xD;
      the outpatient CR facility, so that lifestyle changes achieved at short notice can be&#xD;
      sustainably maintained.&#xD;
&#xD;
      For the secondary prevention of the CVD beyond the CR measure recommend international&#xD;
      guidelines a physical activity of ≥ 150 min with moderate intensity or ≥ 60 to 75 min high&#xD;
      intensity per week. The current study situation allows the statement that a greater benefit&#xD;
      can be expected from more physical activity and that the training should be personalized and&#xD;
      highly titrated. Patients in advanced stages of CVD and very inactive patients, defined as&#xD;
      &lt;14 mets h/week, achieve the greatest health benefit from increased physical activity.&#xD;
      Despite the well-studied benefits, even adherence to the above minimum recommendations for&#xD;
      CVD patients after completion of CR is low. This deficit has been addressed in the latest&#xD;
      European prevention guideline and recommended that patients i) set clearly defined goals, ii)&#xD;
      exercise in the iii) Identify obstacles on the way to achieving the goals so that lifestyle&#xD;
      changes are effective and sustainable and the benefits of physical activity can be achieved&#xD;
      and maintained.&#xD;
&#xD;
      The planned study will investigate the effect of multi-modal support measures to help&#xD;
      patients during the home training phase and their influence on the patients' lifestyle.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 10, 2019</start_date>
  <completion_date type="Anticipated">September 9, 2020</completion_date>
  <primary_completion_date type="Anticipated">September 9, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The change of maximal workload during ergometry pre and post home-training</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Evaluation of Multi-modal Supportive Actions in Outpatient Cardiac Rehabilitation in Subjects With Cardiovascular Disease</condition>
  <arm_group>
    <arm_group_label>Patients who used supportive measures during home training</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>patients who did not use supp. measures during home training</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        All patients who undergo the final examination for OUT-III at one of the outpatient&#xD;
        rehabilitation facilities participating in the study are checked by the examining physician&#xD;
        for the above-mentioned inclusion and exclusion criteria. Patients will be included if they&#xD;
        are willing to participate and sign the consent form.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age &gt;= 18 years&#xD;
&#xD;
          -  Participation rehabilitation phase III new&#xD;
&#xD;
          -  Documented cardiovascular disease&#xD;
&#xD;
          -  Signed informed-consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        -&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Angelika Rzepka, MSc</last_name>
    <phone>0043 664 8561598</phone>
    <email>angelika.rzepka@ait.ac.at</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Dieter Hayn, Dr.</last_name>
    <phone>0043 50550 2953</phone>
    <email>dieter.hayn@ait.ac.at</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Cardiomed Kardiologisches Rehabilitationszentrum GmbH Linz</name>
      <address>
        <city>Linz</city>
        <state>Upper Austria</state>
        <zip>4020</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karl Mayr, Dr.</last_name>
      <phone>0732 797779</phone>
      <email>Karl.Mayr@cardiomed.at</email>
    </contact>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>July 1, 2020</study_first_submitted>
  <study_first_submitted_qc>July 1, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 7, 2020</study_first_posted>
  <last_update_submitted>July 1, 2020</last_update_submitted>
  <last_update_submitted_qc>July 1, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 7, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>rehabilitation</keyword>
  <keyword>cardiovascular disease</keyword>
  <keyword>outpatient cardiac rehabilitation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

